-
DE
Translational inhibition refers to the blocking of protein biosynthesis at the level of translation. It is a key mechanism in medicine, notably in the action of antibiotics.
Translational inhibition refers to the blocking of protein biosynthesis at the level of translation. It is a key mechanism in medicine, notably in the action of antibiotics.
Translational inhibition refers to the deliberate or unintended blocking or slowing of translation – the process by which genetic information encoded in messenger RNA (mRNA) is decoded to produce proteins. Translation is a fundamental step of protein biosynthesis and takes place at the ribosomes. When this process is inhibited, cells can no longer produce functional proteins, with far-reaching consequences for cell growth, metabolism, and survival.
Translation proceeds through three main phases:
Inhibitors of translation can target different phases, selectively or completely blocking protein production.
Many clinically important antibiotics work by inhibiting translation in bacterial cells. Because bacteria possess different ribosomes (70S) compared to human cells (80S), these agents can selectively target bacteria:
Translational inhibition also plays a role in antiviral immune responses. Interferons activate certain enzymes (e.g., PKR – protein kinase R), which inhibit translation in virus-infected cells, thereby limiting viral replication.
Some natural toxins also inhibit translation:
Under stress conditions (e.g., nutrient deprivation, oxidative stress, heat shock), cells can actively downregulate translation to conserve energy. This occurs partly through phosphorylation of the initiation factor eIF2α, a central component of the so-called Integrated Stress Response (ISR).
Translational inhibition is a core mechanism of action in modern medicine. Beyond classical antibiotics, new therapeutic strategies are being explored that aim to selectively trigger translational inhibition in cancer cells to halt their growth. Additionally, natural regulatory mechanisms of translational inhibition are important in:
A key aspect for medical applications is the structural difference between ribosomes of bacteria (prokaryotic, 70S) and human cells (eukaryotic, 80S). Many antibiotics exploit this difference to selectively inhibit bacterial ribosomes without significantly harming human cells.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.